(Q56902608)

2

0 references

B J Shelvin

3

0 references

S Lerner

4

0 references

T J Kipps

5

0 references

M J Keating

6

0 references

W G Wierda

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403907

7

0 references

language of work or name

English

0 references

publication date

October 2005

0 references

published in

Leukemia

0 references

volume

19

0 references

issue

10

0 references

page(s)

1788-93

0 references

exact match

0 references

cites work

CTLA-4 exon 1 polymorphism in patients with autoimmune blood disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403907

A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403907

Analysis of the expression of critical activation/interaction markers on peripheral blood T cells in B-cell chronic lymphocytic leukaemia: evidence of immune dysregulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403907

Alterations of the expression of T-cell-related costimulatory CD28 and downregulatory CD152 (CTLA-4) molecules in patients with B-cell chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403907

Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403907

Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403907

ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403907

Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403907

Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403907

Inhibition of IgG1 and IgE production by stimulation of the B cell CTLA-4 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403907

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403907

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403907

Unusual T-cell phenotype in advanced B-chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403907

7 January 2021

Cutting edge: tyrosine-independent transmission of inhibitory signals by CTLA-4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403907

7 January 2021

CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403907

7 January 2021

CD4+CD25high regulatory cells in human peripheral blood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403907

7 January 2021

Peripheral blood lymphocyte subset shifts in patients with untreated hematological tumors: evidence for systemic activation of the T cell compartment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403907

7 January 2021

Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403907

7 January 2021